" class="no-js "lang="en-US"> Kidney Disease Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

CardioRenal receives FDA Breakthrough Device Designation for TENOR

CardioRenal, a pioneer in the remote treatment of patients with severe chronic kidney disease (CKD), […]

Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease

Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

XORTX Therapeutics, a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive […]

Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis

GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]

Modus Therapeutics Submits Patent Application for Sevuparin in Kidney Disease

Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet medical […]

US FDA Accepts Supplemental New Drug Application for Jardiance® for Adults with Chronic Kidney Disease

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more